Key result
In diabetic patients with STEMI, the presence of microvascular obstruction on CMR was associated with significantly higher periprocedural platelet reactivity to collagen, ADP, TRAP, and arachidonic acid.
Observational (n=30)
No
Answers are grounded in this paper and cite their sources.
Higher periprocedural platelet reactivity may associate with MVO in diabetic STEMI; leaves open whether reactivity-guided therapy improves outcomes.
ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Kuliczkowski W, Miszalski-Jamka K, Kaczmarski J, Pres D, Gąsior M. No-reflow and platelet reactivity in diabetic patients with ST-segment elevation myocardial infarction: is there a link?. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2017;13(4):326-330. doi:10.5114/aic.2017.71615. APA Kuliczkowski, W., Miszalski-Jamka, K., Kaczmarski, J., Pres, D., & Gąsior, M. (2017). No-reflow and platelet reactivity in diabetic patients with ST-segment elevation myocardial infarction: is there a link?. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 13(4), 326-330. https://doi.org/10.5114/aic.2017.71615 Chicago Kuliczkowski, Wiktor, Karol Miszalski-Jamka, Jacek Kaczmarski, Damian Pres, and Mariusz Gąsior. 2017. "No-reflow and platelet reactivity in diabetic patients with ST-segment elevation myocardial infarction: is there a link?". Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej 13 (4): 326-330. doi:10.5114/aic.2017.71615. Harvard Kuliczkowski, W., Miszalski-Jamka, K., Kaczmarski, J., Pres, D., and Gąsior, M. (2017). No-reflow and platelet reactivity in diabetic patients with ST-segment elevation myocardial infarction: is there a link?. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 13(4), pp.326-330. https://doi.org/10.5114/aic.2017.71615 MLA Kuliczkowski, Wiktor et al. "No-reflow and platelet reactivity in diabetic patients with ST-segment elevation myocardial infarction: is there a link?." Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, vol. 13, no. 4, 2017, pp. 326-330. doi:10.5114/aic.2017.71615. Vancouver Kuliczkowski W, Miszalski-Jamka K, Kaczmarski J, Pres D, Gąsior M. No-reflow and platelet reactivity in diabetic patients with ST-segment elevation myocardial infarction: is there a link?. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2017;13(4):326-330. doi:10.5114/aic.2017.71615.
No takes yet. Share an insight, caveat, or question.
Kuliczkowski et al. (2017) conducted an observational in ST-segment elevation myocardial infarction (STEMI) with diabetes (n=30). Microvascular obstruction (MVO) vs. Absence of MVO was evaluated on Collagen-induced platelet aggregation before PCI (AUC, AU·min) (p=<0.001). In diabetic patients with STEMI, the presence of microvascular obstruction on CMR was associated with significantly higher periprocedural platelet reactivity to collagen, ADP, TRAP, and arachidonic acid.
Synapse has enriched 10 related papers. Consider them for comparative context: